JESSICA JENNINGS: Open Payments
NPI 1730728056 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,411 in 43 payments from 6 companies in 2025. Trend: 2023 $417 · 2024 $1,682 · 2025 $1,411
Food & beverage: $1,411
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 11 | $760 |
| Ipsen Biopharmaceuticals, Inc | 27 | $381 |
| Mirum Pharmaceuticals, Inc. | 1 | $142 |
| Stryker Corporation | 1 | $71 |
| Gilead Sciences, Inc. | 2 | $40 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: REZDIFFRA, IQIRVO, Livmarli, Bylvay, GAMMA, Auvelity.
Industry payments across TX — which companies pay providers there.
